Syntaxin

Country UK UK

Website http://www.ipsen.com/fr/recherche-developpement/3-centres-mondiaux-de-reference/oxford-royaume-uni/

Visit

Syntaxin

Syntaxin is an English biotech with a unique know-how in the design, expression, and purification of recombinant botulinum toxins—reflected by a portfolio of 75 granted patents and more than 130 patents pending in 2013.

In July 2013, Ipsen bought Syntaxin in a deal that could reach more than €158 million ($206 million).

Read the press release